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echocardiographic evaluation  
of Patent Ductus Arteriosus in 
Preterm infants
Romaine Arlettaz*
Department of Neonatology, University Hospital Zurich, Zurich, Switzerland
Patent ductus arteriosus (PDA) is part of the typical morbidity profile of the preterm 
infant, with a high incidence of 80–90% in extremely low birth weight infants born before 
26 weeks of gestation. Whereas spontaneous closure of the ductus arteriosus (DA) is 
likely in term infants, it is less so in preterm ones. PDA is associated with increased mor-
tality and various comorbidities including cardiac failure, need for respiratory support, 
bronchopulmonary dysplasia, pulmonary or intracranial hemorrhage, and necrotizing 
enterocolitis; however, there is no proven causality between these morbidities and the 
presence of DA. Thus, the indication to close PDA remains highly controversial. This 
paper focuses on echocardiographic evaluation of PDA in the preterm infant and partic-
ularly on the echocardiographic signs of hemodynamic significance.
Keywords: preterm infant, patent ductus arteriosus, functional echocardiography, extremely low birth weight 
infant, ductus arteriosus
iNTRODUCTiON
Preterm infants account for 6–12% of the newborn population and represent the main group of 
infants treated in neonatal intensive care units. Among the typical complications observed in pre-
term infants, patent ductus arteriosus (PDA) is frequent. Its incidence is inversely proportional to 
the preterm infant’s gestational age, with a rate of about 20% in premature infants born at 32 weeks of 
gestation compared to an estimated 80–90% in extremely low birth weight infants with a gestational 
age of less than 26 weeks (1, 2). The likelihood of spontaneous closure of the ductus arteriosus (DA) 
in full-term infants without congenital heart disease is very high; in the preterm infant, closure rates 
are poorer (1–3). However, recent studies have shown that PDA will have spontaneously closed by 
the end of the first week of life in about 73% of preterm infants with a gestational age of 28 weeks (3).
According to the international literature, PDA is associated with not only increased mortality but 
also various neonatal comorbidities (1, 2, 4, 5). These include cardiac failure, need for respiratory 
support, need for supplemental oxygen, bronchopulmonary dysplasia, pulmonary hemorrhage, 
intraventricular hemorrhage, abnormal cerebral perfusion, and necrotizing enterocolitis. Against 
this background, it became common practice in 1990s to follow a strategy of aggressive medicamen-
tous or surgical closure of PDA in very preterm infants. Nowadays, we know that there is no real 
proven causality between mortality, neonatal morbidities, and PDA (2, 5). The indications to close 
PDA have, therefore, decreased dramatically, and the procedure remains controversial. The current 
approach is to limit treatment to infants most likely to benefit from intervention, i.e., extremely low 
Abbreviations: DA, ductus arteriosus; hsPDA, hemodynamically significant patent ductus arteriosus; LA:Ao, left atrium to 
aortic valve; LAX, long axis view; PDA, patent ductus arteriosus; SAX, short axis view.
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birth weight infants, particularly those on respiratory support 
and at risk of rapidly developing a hemodynamically significant 
PDA (hsPDA) (5).
As clinical signs of PDA are not sensitive or specific enough, 
all extremely preterm infants at risk of developing PDA should 
undergo echocardiography. The main goal of the present review 
is to define and develop the different steps in echocardiographic 
evaluation of PDA in the preterm infant.
eCHOCARDiOGRAPHiC evALUATiON  
OF PDA
General Considerations
It is important to consider some general guidelines when evaluat-
ing PDA. Although DA is the focus of functional echocardiogra-
phy, the baby should always undergo a complete echocardiogram 
first. An initial echocardiogram enables (i) structural congenital 
heart disease to be excluded, (ii) biventricular function to be 
measured, and (iii) different aspects of transitional circulation to 
be checked, as for example pulmonary pressures.
When performing functional echocardiography, it is also 
important to bear in mind the difficulties and challenges asso-
ciated with scanning a premature infant. Some babies are very 
small, they can be agitated or unstable, have a high heart rate, 
and sometimes a poor echo window, particularly if they are 
ventilated and have severe underlying lung disease. Some simple 
tricks include the following: place the baby in the best position 
(slightly turned to the left with a slightly extended neck), scan the 
baby when it is in a quiet and stable state whenever possible, and 
allow plenty of time.
Specific evaluation of PDA
Echocardiographic evaluation of PDA in the preterm infant will 
help physicians answer the following questions: Is the DA patent? 
What is its size? What is the direction of the shunt? Is the PDA 
hemodynamically significant?
Ductal Patency
Patent ductus arteriosus can be seen on each of the classic echo 
views, but the most preferred views are the parasternal short 
axis view (SAX) and the suprasternal view. With SAX, the DA 
is visualized at the base of the heart by moving the probe slightly 
anteriorly toward the pulmonary artery. A small DA can easily 
be missed on 2D pictures, thus pulsed wave Doppler and color 
Doppler are helpful (Figure 1). Pulsed wave Doppler in the main 
pulmonary artery shows a quiet flow when the DA has closed and 
turbulent systolic and diastolic flow when DA is patent (Figure 1). 
For the suprasternal view, the probe should be placed at a sagittal 
level at the midline in order to visualize the pulmonary artery on 
the left and the descending aorta on the right of the picture. The 
DA appears between both great arteries (Figure 2).
Besides the SAX and suprasternal views, it is also possible to 
see the DA in the parasternal long axis view (LAX) by moving 
the probe from the classic LAX anteriorly toward the pulmonary 
artery (Figure 3). The subcostal LAX also allows the detection of 
the DA. The only window which is not appropriate for detecting 
DA is the apical four chamber view.
Ductal Size
The most accurate view for measuring the size of the DA is the 
high left parasternal short axis window, also called “ductal view.” 
Concentrating on the main pulmonary artery, the origin of the 
right pulmonary artery, which is not always visible, and of the 
left pulmonary artery can be visualized; the DA is positioned to 
the left of it. The DA should be measured at its narrowest point, 
before its entry into the main pulmonary artery (Figure 4).
Measurement of the ductal size is not very accurate. It is not 
recommended to use the color Doppler, which can exaggerate the 
size. Measurements must always be performed using a consistent 
technique. A PDA is considered small at <1.5  mm, moderate 
when it ranges between 1.5 and 3 mm, and large if the dimension 
exceeds 3 mm. SAX should not be chosen to measure ductal size 
because it is not always possible to differentiate the left pulmonary 
artery from the DA.
Direction of the Shunt across the PDA
The direction of the shunt across the PDA can be right to left, 
bidirectional, or left to right. In order to document it, color 
Doppler is required. A right-to-left shunt across the PDA is more 
difficult to see: color Doppler will show a flow going from the 
pulmonary artery toward the descending aorta. Thus, both great 
arteries and the DA will appear blue on color Doppler because 
the blood moves away from the transducer. Placing pulsed 
wave Doppler over the DA shows a Doppler wave below the 
baseline, usually during systole. Less often, a continuous flow 
during systole and diastole can be observed, representing a pure 
right-to-left shunt (Figure  5). When the pulmonary vascular 
resistance falls, the shunt will be bidirectional with a flow above 
the baseline during the systole and below the baseline during the 
diastole (Figure 6). Velocities are usually low and suggest equal 
pressure in the pulmonary artery and the descending aorta. Color 
Doppler shows alternating red and blue. Once the pulmonary 
pressure drops further, the shunt will be left to right and appears 
red on color Doppler. On pulsed or continuous wave Doppler, 
maximal velocities during systole and diastole can be measured, 
see below. It is also possible to demonstrate shunt direction on 
color Doppler using M-Mode (Figure 6).
Is the PDA Hemodynamically Significant?
In a physiological state, the pulmonary to systemic flow ratio 
(Qp:Qs) is 1. The right ventricular output reflects the systemic 
blood flow whereas the left ventricular output reflects the pul-
monary blood flow. The shunt across the patent foramen ovale 
influences the right ventricular output, and the shunt across the 
PDA influences the left ventricular output. Thus, ventricular 
output measurements in a newborn infant with open DA and 
foramen ovale are not very accurate.
In the case of hsPDA, the pulmonary blood flow increases due 
to the amount of blood running back from the descending aorta 
into the lung circulation through PDA; this pattern is known as 
steal phenomenon. At the same time, the systemic blood flow 
decreases for the same reason. Qp:Qs ratio will increase.
FiGURe 1 | Visualization of patent ductus arteriosus in short axis view (SAX). (A) 2D SAX moved anteriorly, (B) same picture with color Doppler, (C) Doppler in the 
main pulmonary artery by closed duct, and (D) Doppler in the main pulmonary artery by patent duct. MPA, main pulmonary artery; RPA, right pulmonary artery; LPA, 
left pulmonary artery; AAo, ascending aorta.
FiGURe 2 | Visualization of patent ductus arteriosus (PDA) in suprasternal view. (A) Normal suprasternal view of the aortic arch, (B) suprasternal sagittal view with 
pulmonary artery and descending aorta, and (C) color Doppler in a sagittal suprasternal view with PDA in red.
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There is no clear clinical definition of hsPDA. Sosenko et al. 
(6) mentioned hsPDA in the presence of clinical signs of PDA 
associated either with pulmonary hemorrhage, or with cardio-
megaly and signs of pulmonary edema, as well as respiratory failure 
and/or arterial hypotension requiring vasopressor treatment. 
McNamara and Sehgal (7) proposed a staging system with a 
comparison between clinical and echocardiographic criteria of 
hsPDA.
FiGURe 4 | Measurement of patent ductus arteriosus (PDA) size on suprasternal view. MPA, main pulmonary artery; RPA, right pulmonary artery; LPA, left 
pulmonary artery.
FiGURe 3 | Visualization of patent ductus arteriosus in long axis view (LAX). (A) 2D classical LAX, (B) LAX slightly tilted anteriorly toward the pulmonary artery, and 
(C) main pulmonary artery with pulmonary branches. RV, right ventricle; LV, left ventricle; AV, aortic valve; PV, pulmonary valve; MPA, main pulmonary artery; RPA, 
right pulmonary artery; LPA, left pulmonary artery.
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The main echocardiographic criteria mentioned in the literature 
include an enlargement of the left atrium with a left atrium to aor-
tic valve (LA:Ao) ratio of ≥1.5, and absent or retrograde diastolic 
flow in the descending aorta, absent or retrograde diastolic flow 
in the mesenteric superior artery and/or in the anterior cerebral 
artery, a moderate to large PDA diameter of ≥  1.5  mm at the 
narrowest point, and an unrestrictive pulsatile transductal flow 
(2, 5, 6, 8–12).
How Can We Measure These Parameters?
LA:Ao ratio is measured on parasternal LAX using M-Mode 
(Figure  7). A cut is made in the left atrium at the level of the 
aortic valve, with the transducer placed perpendicular to it. The 
aortic valve is measured just before its opening, at the end of 
the diastole, whereas the left atrium is measured at its maximal 
volume during the systole. The LA:Ao ratio should not exceed 1.5. 
This measurement is easy to perform but not very accurate for 
two reasons: first, the left atrium is not always easy to delimitate, 
particularly because of the entrance of the pulmonary veins 
into it. Second, the atrial shunt influences LA:Ao ratio as a large 
foramen ovale or atrial septal defect will allow the engorged left 
atrium to empty into the right one.
A further sign of hsPDA is the absent or retrograde diastolic 
flow in the descending aorta. In order to visualize this, the 
FiGURe 5 | Right-to-left shunt across the patent ductus arteriosus (PDA). (A) Short axis view; color Doppler flow pattern is blue during systole and diastole, (B) flow 
across the PDA is below the baseline during systole, and (C) flow across the PDA is below the baseline during systole and diastole in the case of “pure right-to-left 
shunt.” MPA, main pulmonary artery; RPA, right pulmonary artery; LPA, left pulmonary artery.
FiGURe 6 | Suprasternal view with (A) bidirectional shunt, (B) bidirectional shunt predominantly left-to-right, (C) left-to-right shunt on color Doppler, and  
(D) left-to-right shunt on color Doppler M-Mode.
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FiGURe 7 | Measurement of LA:Ao ratio in parasternal long axis view in 
M-Mode.
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FiGURe 8 | Suprasternal view: (A) color Doppler of the postductal descending aorta with (B) normal anterograde flow, (C) absent end diastolic flow, and  
(D) pandiastolic retrograde flow.
transducer has to be placed in the postductal descending aorta; 
the pulsed wave Doppler is used. In a physiological situation, the 
Doppler wave is anterograde during the systole and the diastole, 
with the wave seen under the baseline. When the steal phenom-
enon appears, the end diastolic flow will be absent, and if the 
Qp:Qs ratio further increases, the flow will be retrograde during 
the whole diastole, appearing above the baseline (Figure  8). 
This measurement is one of the most specific in evaluating the 
hemodynamic significance of PDA.
In a similar way, the diastolic flow is measured in the 
abdominal descending aorta and in the mesenteric superior 
artery. Again, the diastolic flow should be anterograde and 
is seen as a Doppler curve above the baseline. In the case of 
hsPDA, it can be absent or even appear retrograde (Figure 9). 
In this case, the perfusion of the small intestine is assumed to 
be compromised.
Last but not least, the Doppler flow pattern across the PDA 
is measured. This will show one of three patterns (Figure 10). 
7Arlettaz Echocardiographic Evaluation of PDA
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FiGURe 9 | Subcostal view of the descending aorta abdominalis with visualization of the truncus coeliacus and superior mesenteric artery, (A) on 2D, (B) on color 
Doppler, (C) with anterograde flow, (D) with absent end diastolic flow, and (e) with retrograde flow. TC, truncus coeliacus; SMA, superior mesenteric artery.
FiGURe 10 | Transductal flow on Doppler in short axis view or suprasternal view: (A,B) unrestrictive pulsatile flow and (C) restrictive continuous flow.
Non-hemodynamically significant PDA has a high flow velocity 
during systole and diastole with a maximal velocity above 2 m/s 
at the end of the diastole; this is called “restrictive continuous 
transductal flow.” If the PDA is moderately hemodynamically 
significant, the Doppler flow pattern has a maximal dias-
tolic velocity of less than 2  m/s and is called “unrestrictive 
8Arlettaz Echocardiographic Evaluation of PDA
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pulsatile transductal flow.” In a large hsPDA, the flow is also 
an “unrestrictive pulsatile transductal flow” but the maximal 
end-diastolic velocity is below 1 m/s. Next to the absolute values, 
it is also possible to measure the ratio between the systolic and 
diastolic velocities. If the peak diastolic velocity is more than 
50% of the peak systolic velocity, the flow pattern is restrictive. 
If this ratio is less than 50%, the flow pattern is pulsatile suggest-
ing hemodynamically significant PDA.
Summary of Echocardiographic  
Parameters of PDA
The most specific echocardiographic parameters of PDA can 
be divided into three groups: (i) the ductal characteristics, 
(ii) overcirculation of the lungs, and (iii) systemic hypoperfusion. 
The latter two are observed in the case of hsPDA.
The Characteristics of PDA
The characteristics of PDA are best evaluated by measuring 
the ductal size and the velocities across the DA, both in a 
suprasternal sagittal view. The ductal diameter measured on 
the first day of life has a high sensitivity and specificity in 
predicting the development of hsPDA (2). Further authors also 
describe the association between ductal size and the need for 
further medicamentous or surgical closure (13). Measuring 
flow velocities from the suprasternal view gives information 
about the direction of the shunt and allows pulmonary pres-
sures to be assessed. Furthermore, quantification of the systolic 
and diastolic flow velocities across the PDA and particularly 
the peak systolic to end diastolic flow velocity ratio is a good 
predictor of ductal patency in preterm infants born before 
32 weeks of gestation (14).
Pulmonary Hyperperfusion
Pulmonary hyperperfusion is best documented with a LA:Ao 
ratio of ≥1.5, an increased flow across the mean pulmonary 
artery, an elevated diastolic flow in the left pulmonary artery, 
and a mitral E/A ratio of >1.5 suggesting severe left heart 
pressure loading (2, 7). The most popular echocardiographic 
parameter is the LA:Ao ratio which is easy to measure. However, 
this parameter is influenced by the shunt across the patent fora-
men ovale.
Systemic Hypoperfusion
Systemic hypoperfusion is best evaluated with the presence of a 
retrograde flow in the descending aorta as well as in the anterior 
cerebral and the superior mesenteric arteries.
These parameters help to grade PDA as non-symptomatic, 
or mildly, moderately, or severely hemodynamically significant. 
The literature fails to agree on the best parameters for assess-
ing ductal significance, but Condo et al. suggested ductal size 
and flow patterns to be the most sensitive (9). However, these 
parameters have to be related to the clinical symptoms pre-
sented by the baby as well as its postnatal age. The hemodynamic 
transition, characterized by an elevated pulmonary vascular 
resistance, will be reflected on echocardiography by a predomi-
nantly right-to-left shunt in the first minutes of life, followed 
by a bidirectional shunt and later a left-to-right shunt with low 
ductal flow velocities (15). With the physiological lowering and 
normalization of the pulmonary pressures, an increase in the 
systolic and diastolic velocities is observed. Also, the ductal size 
measured in the first 2 days of life is a good predictor of develop-
ment of symptomatic DA, which is not the case later in life. 
Thus, the approach used in assessing hsPDA varies according 
to the timing of echo.
DiSCUSSiON
Echocardiographic evaluation of PDA in very preterm infants is 
one of the everyday activities in a neonatal intensive care unit and 
is usually performed by not only pediatric cardiologists but also 
by neonatologists or pediatric intensivists trained in functional 
echocardiography. It is not easy to perform echocardiograms in 
extremely preterm infants, and the fact that there is intra- as well 
as interobserver variability is certainly not optimal. Thus, it is 
important to follow some basic rules. First, echocardiogram can 
focus on PDA only after a previous complete echo has excluded 
structural congenital heart disease and measured ventricular 
function. Second, scanning a preterm infant can be challeng-
ing, and the evaluation of PDA is time consuming, so it is also 
important to keep in mind the general considerations described 
in this review.
If the echocardiogram of a preterm infant with PDA has been 
performed by a neonatologist or intensivist, the echocardio-
graphic findings should be confirmed by a pediatric cardiologist 
and a joint decision should be taken regarding treatment of PDA 
and follow-up of the baby.
The debate on whether or not to treat PDA is beyond the 
scope of the present review. However, many authors suggest 
treating only babies presenting with hsPDA and showing clini-
cal signs of respiratory failure. Indeed, a baby doing very well 
and not requiring ventilator support or supplemental oxygen 
will usually not benefit from ductal closure. In this sense, echo-
cardiographic evaluation of PDA should be accompanied by the 
definition of its clinical significance. One possible approach is 
the staging system published 10 years ago by McNamara and 
Sehgal (7), setting out a detailed correlation between the clinical 
and echocardiographic signs. Neonatologists may find this help-
ful in deciding if and when to start medicamentous treatment 
in order to close PDA.
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